Pasithea Therapeutics (KTTA) Asset Utilization Ratio (2022 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.01 as the latest value for Q1 2024.
- Quarterly Asset Utilization Ratio rose 51.29% to 0.01 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 0.01 through Mar 2024, up 51.29% year-over-year, with the annual reading at 0.01 for FY2022, N/A changed from the prior year.
- Asset Utilization Ratio hit 0.01 in Q1 2024 for Pasithea Therapeutics, up from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2023 to a low of 0.0 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.01 across 3 years, with a median of 0.01 in 2023.
- Biggest YoY gain for Asset Utilization Ratio was 3521.49% in 2023; the steepest drop was 1.12% in 2023.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then dropped by 1.12% to 0.01 in 2023, then surged by 41.22% to 0.01 in 2024.
- Business Quant data shows Asset Utilization Ratio for KTTA at 0.01 in Q1 2024, 0.01 in Q4 2023, and 0.02 in Q3 2023.